Preethi Sundaram serves as Executive at CATALYST PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Preethi Sundaram has executed 17 insider transactions totaling $1.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 29, 2025 involved selling 2,369 shares valued at $0.
Preethi Sundaram currently holds 54,804 shares of CATALYST PHARMACEUTICALS, INC. (CPRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Preethi Sundaram has been a net seller of CPRX stock. They have purchased $0 and sold $1.2M worth of shares.
Preethi Sundaram's most recent insider trade was on Dec 29, 2025, when they sold 2,369 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 8, 2025 | CPRX | $0 | Option Exercise | 6,855 | $N/A | Discretionary |
| Dec 8, 2025 | CPRX | $0 | Payment | 1,669 | $N/A | Discretionary |
| Nov 21, 2025 | CPRX | $0 | Payment | 1,364 | $N/A | Discretionary |
| Nov 21, 2025 | CPRX | $0 | Option Exercise | 5,603 | $N/A | Discretionary |
| Feb 15, 2024 | CPRX | $0 | Payment | 6,025 | $N/A | Discretionary |
| Feb 15, 2024 | CPRX | $0 | Option Exercise | 16,667 | $N/A | Discretionary |
| Dec 27, 2023 | CPRX | $0 | Payment | 2,409 | $N/A | Discretionary |
| Dec 27, 2023 | CPRX | $0 | Option Exercise | 6,666 | $N/A | Discretionary |
| Feb 15, 2023 | CPRX | $0 | Option Exercise | 16,666 | $N/A | Discretionary |
| Feb 15, 2023 | CPRX | $0 | Payment | 6,024 | $N/A | Discretionary |
| Nov 11, 2022 | CPRX | $468.5K | Sale | 28,393 | $16.50 | Discretionary |
| Nov 11, 2022 | CPRX | $461.4K | Sale | 28,393 | $16.25 | Discretionary |
| Nov 11, 2022 | CPRX | $311.8K | Option Exercise | 56,786 | $5.49 | Discretionary |
| Sep 15, 2022 | CPRX | $100.0K | Option Exercise | 18,214 | $5.49 | Discretionary |
| Sep 15, 2022 | CPRX | $263.9K | Sale | 18,214 | $14.49 | Discretionary |